Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds
More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
Patents for C07D - Heterocyclic compounds (10,420)
08/1997
08/28/1997WO1997030992A1 Inhibitors of farnesyl protein transferase
08/28/1997WO1997009297A3 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
08/28/1997CA2246051A1 Azabicyclic esters of carbamic acids useful in therapy
08/27/1997EP0790826A1 Dihydropyrimidines and uses thereof
08/27/1997EP0647231B1 N-substituted 3-azabicyclo[3.2.0]heptane derivatives useful as neuroleptic agents, etc.
08/27/1997EP0592438B1 Indole derivatives
08/26/1997US5661155 Treatment of cancer with pharmaceutically active benzoquinazoline compounds
08/26/1997CA1339373C 6-7-disubstituted 1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-c arboxylic acids
08/21/1997WO1997030046A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists
08/21/1997CA2245684A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists
08/20/1997EP0789697A1 NOVEL CRYSTAL FORM OF ANHYDROUS 7-((1a,5a, 6a)-6-AMINO-3-AZABICYCLO ( 3.1.0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT
08/20/1997CN1035669C Method for preparation of useful intermediate compound during preparing aromatic pyrrole insecticide
08/19/1997US5658928 Anticoagulants, antiinflammatory agents, antitumor agents,wound healing agents, osteoporosis
08/19/1997US5658921 Potent sigma receptor ligands; water solubility; symmetry
08/19/1997US5658911 Heteroarylpiperidines, and their use as antipsychotics and analgetics
08/19/1997CA1339295C Surface active lactams
08/13/1997EP0691957B1 (s)-alpha-phenyl-2-pyridineethanamine (s)-malate and its use as a medicament
08/13/1997EP0486666B1 Therapeutic heterocyclic compounds
08/13/1997CN1156725A Intermediates for making 4-chloro-2-thiophenecarboxylic acid and process of preparing them
08/13/1997CN1156722A 3-amino-2-mercaptobenzoic acid derivatives and processes for their preparation
08/13/1997CN1035616C 异羟肟酸衍生物 Hydroxamic acid derivatives
08/13/1997CA2197393A1 Triazine containing anionic compounds useful as antiviral agents
08/06/1997CN1035555C Process for diastereoselective synthesis of nucleosides
08/05/1997US5654299 Aryl substituted heterocycles
08/05/1997CA1339213C Substantially anhydrous crystalline cefadroxil and method for producing it
07/1997
07/31/1997WO1997027176A1 Optical resolution of methylphenidate by 0,0'-bisaroyl tartaric acids
07/31/1997CA2242595A1 Optical resolution of methylphenidate by 0,0'-bisaroyl tartaric acids
07/30/1997EP0786458A2 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
07/30/1997EP0785790A1 Use of anthocyanidin and derivatives for treatment of retroviral infections
07/29/1997US5652361 Macrocyclic ligands and complexes
07/29/1997CA1339107C 2,5-diketogluconic acid reductase purification and use in ascorbic acid production
07/23/1997EP0784620A1 N-substituted piperidinyl bicyclic benzoate derivatives
07/17/1997WO1997025322A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
07/16/1997EP0783507A1 Compounds useful as antiproliferative agents and garft inhibitors
07/16/1997EP0783495A1 Quinoxaline derivatives useful in therapy
07/16/1997CN1154692A 2-£(dihydro) pyrazolyl-3'-oxymethyene|-anilides, prepn. method and use thereof
07/15/1997US5648502 Regioselective synthesis of 4-chloro-2-thiophenecarboxylic acid
07/15/1997US5648379 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
07/15/1997CA2069063C Processes for the diastereoselective synthesis of nucleosides
07/10/1997WO1997024356A1 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
07/08/1997US5646168 Hypoglycemic hydroxyurea derivatives
07/08/1997US5646144 For treating disorders in which substance p plays a part in development
07/03/1997WO1997023499A1 Prodrugs of thrombin inhibitors
07/03/1997CA2238737A1 Prodrugs of thrombin inhibitors
07/02/1997EP0781136A1 Compounds and methods for the treatment of cancer
06/1997
06/26/1997WO1997022593A1 Novel 5-amino-3-cyano-4-ethylsulfinyl-1-phenyl-pyrazole compounds and their use as pesticides
06/26/1997DE19653417A1 Neue Aminopyrazole und ihre Verwendung als Pestizide New aminopyrazoles and their use as pesticides
06/25/1997EP0780372A2 3-Amino-2-mercaptobenzoic acid derivatives and processes for their preparation
06/25/1997CN1152918A Novel amido quinoxaline diones, their production and use
06/19/1997WO1997021685A1 Retroviral protease inhibiting compounds
06/19/1997CA2509505A1 Retroviral protease inhibiting compounds
06/18/1997CN1035181C Process for prep. of 3-unsaturated alkyl cephems from 3-triflyl cepheme
06/12/1997WO1997020829A1 Process for preparing 2-chlorothiazole compounds
06/12/1997WO1997020824A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation
06/12/1997WO1997020815A1 Compounds
06/12/1997CA2591794A1 Process for preparing intermediates useful in preparing 2-chlorothiazole compounds
06/12/1997CA2238306A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation
06/11/1997EP0777671A1 Spiro-azabicyclic compounds useful in therapy
06/11/1997CN1035112C Improved process for useful diazinylpiperides derivatives
06/10/1997US5637624 Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes
06/10/1997US5637611 Vasoconstructive agents; migraine
06/04/1997EP0776324A1 Endothelin antagonists
06/03/1997US5635507 Pharmacologically active CNS compounds
05/1997
05/29/1997WO1997019062A1 Substituted aryl or heteroarylamides having retinoid-like biological activity
05/29/1997CA2238310A1 Substituted aryl or heteroarylamides having retinoid-like biological activity
05/21/1997CN1150424A Pyranone compounds useful to treat retroviral infections
05/21/1997CN1150020A Anti-viral compounds
05/15/1997WO1997017343A1 Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands
05/15/1997CA2236678A1 Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands
05/14/1997EP0772605A1 Benzoxazoles and pyridine derivatives useful in the treatment of the type ii diabetes
05/14/1997CN1149871A Process for diastereoselective synthesis of nucleoside analogues
05/09/1997WO1997016439A1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
05/07/1997CN1034805C Preparation of amino acid derivatives
05/06/1997US5627278 Process for preparing compounds containing a fused bicyclic ring
05/06/1997US5627191 Therapeutic agents
04/1997
04/30/1997CN1148855A Novel spiro [indole-pyrrolidine]derivatives as melatoninergic agonists, method for preparing same and use thereof as drug
04/30/1997CN1148849A Process for preparing anhydrous and hydrate forms of antihistaminic pipeeridine derivatives, polymorphs and spseudormophs thereof
04/30/1997CN1148596A Noval crystal type anhydrous 7-([1 alpha, 5 alpha, 6 alpha]-6-amino-3-azabicyclo[3,1,0]hexyl-3-group)-6-fluorine-1-(2,4-difluorophenyl
04/29/1997US5625066 Optically active hydroquinine (amino-3 phenyl)-1 ethanesulfonate, preparation and use thereof
04/29/1997US5624941 Pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present
04/29/1997US5624923 Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
04/24/1997WO1997014686A1 Pharmaceutically active quinazoline compounds
04/24/1997CA2235304A1 Pharmaceutically active quinazoline compounds
04/23/1997EP0768884A1 Drugs containing metronidazole or a synergistic mixture of metronidazole and clindamycin
04/22/1997US5623069 Phosphorylation of nucleoside in an organic phosphate solvent using phosphorus oxyhalogenide
04/16/1997CN1034552C Preparation of decahydro-isoquinoline derivatives
04/10/1997WO1997012870A1 Tetrahydroquinolines as nmda antagonists
04/10/1997CA2232509A1 Tetrahydroquinolines as nmda antagonists
04/09/1997EP0766668A1 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof
04/09/1997EP0599890B1 Geneserine derivatives as cholinesterase inhibitors
04/01/1997US5616721 Cyclization of the corresponding phenol compound
03/1997
03/27/1997WO1997004788A3 Use of calendula glycosides for the treatment of psoriasis
03/26/1997CN1146205A Preparation of arthropodicidal oxadiazines
03/25/1997US5614628 Antitumor
03/25/1997US5614470 13-substituted milbemycin derivatives, their preparation and their use
03/25/1997US5614180 Shampoo-conditioner composition
03/25/1997CA1339022C Lactam derivatives
03/20/1997WO1997010227A1 Benzothiazolone derivatives
03/20/1997WO1997003654A3 Pharmaceutical compositions
03/20/1997CA2231003A1 Benzothiazolone derivatives
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 105